Trastuzumab Active Not Recruiting Phase 3 Trials for HER2 Positive Breast Cancers Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Active Not Recruiting | Treatment | 3 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT03013504 | A Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of HD201 to Herceptin® in HER2+ Early Breast Cancer Patients |